Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel-Reference-Cited by-同舟云学术

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Published:2021-02-28 Issue:6 Volume:10 Page:1936-1943
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hoogland Aasha I.¹^ORCID,Jayani Reena V.²,Collier Aaron¹,Irizarry‐Arroyo Nathaly¹,Rodriguez Yvelise¹,Jain Michael D.³,Booth‐Jones Margaret⁴,Hyland Kelly A.¹^ORCID,James Brian W.¹,Barata Anna¹,Bachmeier Christina A.³,Chavez Julio C.⁵,Khimani Farhad³,Krivenko Gabriel S.³,Lazaryan Aleksandr³,Liu Hien D.³,Nishihori Taiga³^ORCID,Pinilla‐Ibarz Javier⁵,Shah Bijal D.⁵,Abidi Muneer⁶,Locke Frederick L.³,Jim Heather S. L.¹^ORCID

Affiliation:

1. Moffitt Cancer Center Department of Health Outcomes and Behavior Tampa FL USA

2. Vanderbilt University Medical Center Department of Medicine Division of Hematology/Oncology Nashville TN USA

3. Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy Tampa FL USA

4. Moffitt Cancer Center Department of Supportive Care Medicine Tampa FL USA

5. Moffitt Cancer Center Department of Malignant Hematology Tampa FL USA

6. Spectrum Health Cancer Center Michigan State University Grand Rapids MI USA

Funder

National Institutes of Health

Publisher

Wiley

Subject